Foreign-Trade Zone 230 Greensboro, North Carolina Application for Subzone; Banner Pharmacaps, Inc.; (Pharmaceutical and Soft Gelatin Capsule Manufacturing) High Point, North Carolina, 10421-10422 [E8-3709]

Download as PDF Federal Register / Vol. 73, No. 39 / Wednesday, February 27, 2008 / Notices Zones Board, Room 2814B, U.S. Department of Commerce, 1401 Constitution Avenue, NW, Washington, DC 20230–0002. For further information, contact Pierre Duy at pierre_duy@ita.doc.gov, or (202) 482– 1378. Dated: February 19, 2008. Andrew McGilvray, Executive Secretary. [FR Doc. E8–3710 Filed 2–26–08; 8:45 am] BILLING CODE 3510–DS–S DEPARTMENT OF COMMERCE Foreign–Trade Zones Board (Docket 7–2008) jlentini on PROD1PC65 with NOTICES Foreign–Trade Zone 227 -- Durant, Oklahoma; Application for Expansion An application has been submitted to the Foreign–Trade Zones (FTZ) Board (the Board) by Rural Enterprises of Oklahoma, Inc., grantee of FTZ 227, requesting authority to expand its existing zone to include two new sites in Carter County, Oklahoma, adjacent to the Dallas/Fort Worth Customs and Border Protection port of entry. The application was submitted pursuant to the provisions of the Foreign–Trade Zones Act, as amended (19 U.S.C. 81a– 81u), and the regulations of the Board (15 CFR part 400). It was formally filed on February 8, 2008. FTZ 227 was approved on January 27, 1998 (Board Order 947, 63 FR 5929, 2/ 5/98). The zone project currently consists of 30 acres within the 280–acre Texoma Industrial Park located near U.S. Highway 69/75 in Durant. The applicant is now requesting authority to expand the zone to include two sites in Carter County: Proposed Site 2 (2,790 acres)—Ardmore Industrial Airpark located on Highway 53 in Springer; and, Proposed Site 3 (122 acres)—Westport Industrial Park located west of Interstate 35 between Prairie Valley Road and 12th Avenue NW in Ardmore. Proposed Site 2 is owned by the Ardmore Development Authority, City of Ardmore, Sovereign Oklahoma Development L.L.C. and Highway 53, L.L.C. Proposed Site 3 is owned by Ardmore Development Authority, JVS, Inc., Premium Beers of Oklahoma, L.L.C., Longhorn Scooters, Inc., KRC Investments, LLC, and Sooner Lift, Inc. The sites will provide warehousing and distribution services to area businesses. No specific manufacturing authority is being requested at this time. Such requests would be made to the Board on a case–by-case basis. VerDate Aug<31>2005 19:49 Feb 26, 2008 Jkt 214001 In accordance with the Board’s regulations, a member of the FTZ Staff has been designated examiner to investigate the application and report to the Board. Public comment is invited from interested parties. Submissions (original and 3 copies) shall be addressed to the Board’s Executive Secretary at the address below. The closing period for their receipt is April 28, 2008. Rebuttal comments in response to material submitted during the foregoing period may be submitted during the subsequent 15-day period to May 12, 2008. A copy of the application and accompanying exhibits will be available for public inspection at each of the following locations: Office of Rural Enterprises of Oklahoma, Inc., 2912 Enterprise Boulevard, Durant, OK 74701; and, Office of the Executive Secretary, Foreign–Trade Zones Board, Room 2111, U.S. Department of Commerce, 1401 Constitution Avenue, NW, Washington, DC 20230. For further information, contact Camille Evans at CamillelEvans@ita.doc.gov or at (202) 482–2350. Dated: February 11, 2008. Andrew McGilvray, Executive Secretary. [FR Doc. E8–3707 Filed 2–26–08; 8:45 am] BILLING CODE 3510–DS–S DEPARTMENT OF COMMERCE Foreign–Trade Zones Board [Docket 8–2008] Foreign–Trade Zone 230 Greensboro, North CarolinaApplication for Subzone; Banner Pharmacaps, Inc.; (Pharmaceutical and Soft Gelatin Capsule Manufacturing) High Point, North Carolina An application has been submitted to the Foreign–Trade Zones (FTZ) Board (the Board) by the Piedmont Triad Partnership, grantee of FTZ 230, requesting special–purpose subzone status with manufacturing authority for certain prescription pharmaceutical products and soft gelatin capsules at the manufacturing facility of Banner Pharmacaps, Inc. (Banner), located in High Point, North Carolina. The application was submitted pursuant to the Foreign–Trade Zones Act, as amended (19 U.S.C. 81a–81u), and the regulations of the Board (15 CFR part 400). It was formally filed on February 12, 2008. The proposed subzone facility (51.3 acres, 2 buildings totaling 263,000 sq. ft. PO 00000 Frm 00004 Fmt 4703 Sfmt 4703 10421 approx. 40% of which is devoted to manufacturing) is located at 4125 Premier Drive in High Point, North Carolina. Banner is a contract manufacturer of soft gelatin capsules for prescription and over–the-counter (OTC) pharmaceuticals, and nutritional products. The Banner facility (500 employees) has requested authority to manufacture under zone procedures a variety of prescription pharmaceutical products that fall within HTSUS categories 3004.50 and 3004.90 (duty– free). The initial products within these categories to be manufactured under FTZ procedures are a treatment for obesity, using active ingredient MK– 0364; and, a drug for the prevention of organ rejection, using ISA 247. These ingredients are classified under HTSUS 2933.39 6.5% duty rate. Other potential products include treatments for obesity, migraines, organ rejection prevention, seizures, Parkinson’s disease, viral infections, cold and cough, and prescription vitamin D. Banner is requesting authority to make these products with active ingredients that fall within the following categories: HTSUS 2915.90, 2921.30, 2922.49, 2933.39, 2933.79, 2935.00, and 3503.00. Active ingredients from these categories specifically cited in the application include valproic acid, amantadine, benzonatate, ethosuximide, cyclosporine, nimodipine, and zonisamide. Foreign–origin active ingredient inputs to be used in the manufacturing process (up to 50 percent of finished product value) have duty rates ranging from 3.7 percent to 6.5 percent, ad valorem. For each of the finished prescription pharmaceutical products (HTSUS 3004.50 and 3004.90), the active ingredients may be combined with edible gelatin (HTSUS 3503.00 ¥ 2.8 cents/kg. + 3.8÷) and a non–active filler ingredient (HTSUS 3906.10 ¥ 6.3÷). Banner is also applying to produce over–the-counter pharmaceutical and nutritional products (HTSUS 3004.90 and 3004.50 duty–free, HTSUS 1517.90 ¥ 8%, and HTSUS 2106.90 ¥ 6.4÷) under zone procedures with requested authority limited to a single foreign– sourced input: edible gelatin (HTSUS 3503.00 ¥ 2.8 cents/kg. + 3.8÷). FTZ procedures would exempt Banner from customs duty payments on foreign materials used in export production. Some 5 to 10 percent of the plant’s shipments are exported. On its domestic shipments, Banner could defer duty until the products are entered for consumption, and choose the duty–free rate that applies to the finished product for the foreign components used in E:\FR\FM\27FEN1.SGM 27FEN1 10422 Federal Register / Vol. 73, No. 39 / Wednesday, February 27, 2008 / Notices production. The company may also realize certain logistical/procedural savings related to zone–to zone transfers and direct delivery procedures, as well as savings on materials that become scrap/waste during manufacturing. The application indicates that FTZ procedures would help improve the plant’s international competitiveness. In accordance with the Board’s regulations, a member of the FTZ staff has been designated examiner to investigate the application and report to the Board. Public comment is invited from interested parties. Submissions (original and 3 copies) shall be addressed to the Board’s Executive Secretary at the address below. The closing period for their receipt is April 28, 2008. Rebuttal comments in response to material submitted during the foregoing period may be submitted during the subsequent 15-day period (to May 12, 2008). A copy of the application will be available for public inspection at each of the following locations: U.S. Department of Commerce Export Assistance Center, 342 North Elm St., Greensboro, NC 27401; and, Office of the Executive Secretary, Foreign–Trade Zones Board, Room 2111, U.S. Department of Commerce, 1401 Constitution Avenue, NW, Washington, D.C. 20230–0002. For further information, contact Diane Finver at Diane_Finver@ita.doc.gov or (202) 482–1367. Dated:February 15, 2008. Andrew McGilvray, Executive Secretary. [FR Doc. E8–3709 Filed 2–26–08; 8:45 am] BILLING CODE 3510–DS–S DEPARTMENT OF COMMERCE Bureau of Industry and Security Regulations and Procedures Technical Advisory Committee; Notice of Partially Closed Meeting jlentini on PROD1PC65 with NOTICES The Regulations and Procedures Technical Advisory Committee (RPTAC) will meet March 11, 2008, 9 a.m., Room 3884, in the Herbert C. Hoover Building, 14th Street between Constitution and Pennsylvania Avenues, NW., Washington, DC. The Committee advises the Office of the Assistant Secretary for Export Administration on implementation of the Export VerDate Aug<31>2005 19:49 Feb 26, 2008 Jkt 214001 Administration Regulations (EAR) and provides for continuing review to update the EAR as needed. Agenda Public Session 1. Opening remarks by the Chairman. 2. Presentation of papers or comments by the Public. 3. Opening remarks by Bureau of Industry and Security. 4. RPTAC comments on Simplified Network Application Process-Redesign System (SNAP–R). 5. Working group reports. 6. Regulations update. 7. Export Enforcement update. 8. Automated Export System (AES) update. Closed Session 9. Discussion of matters determined to be exempt from the provisions relating to public meetings found in 5 U.S.C. app. 2 §§ 10(a)(1) and 10(a)(3). The open session will be accessible via teleconference to 20 participants on a first come, first serve basis. To join the conference, submit inquiries to Ms. Yvette Springer at Yspringer@bis.doc.gov no later than March 4, 2008. A limited number of seats will be available for the public session. Reservations are not accepted. To the extent that time permits, members of the public may present oral statements to the Committee. The public may submit written statements at any time before or after the meeting. However, to facilitate the distribution of public presentation materials to the Committee members, the Committee suggests that presenters forward the public presentation materials prior to the meeting to Ms. Springer via e-mail. The Assistant Secretary for Administration, with the concurrence of the delegate of the General Counsel, formally determined on February 14, 2008, pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. app. 2 §§ (10)(d)), that the portion of the meeting dealing with matters the disclosure of which would be likely to frustrate significantly implementation of an agency action as described in 5 U.S.C. 552b(c)(9)(B) shall be exempt from the provisions relating to public meetings found in 5 U.S.C. app. 2 §§ 10(a)(1) and 10(a)(3). The remaining portions of the meeting will be open to the public. PO 00000 Frm 00005 Fmt 4703 Sfmt 4703 For more information, call Yvette Springer at (202) 482–2813. Dated: February 21, 2008. Yvette Springer, Committee Liaison Officer. [FR Doc. E8–3660 Filed 2–26–08; 8:45 am] BILLING CODE 3510–JT–P DEPARTMENT OF COMMERCE International Trade Administration Initiation of Antidumping and Countervailing Duty Administrative Reviews Import Administration, International Trade Administration, Department of Commerce. SUMMARY: The Department of Commerce (the Department) has received requests to conduct administrative reviews of various antidumping and countervailing duty orders and findings with January anniversary dates. In accordance with the Department’s regulations, we are initiating those administrative reviews. EFFECTIVE DATE: February 27, 2008. FOR FURTHER INFORMATION CONTACT: Sheila E. Forbes, Office of AD/CVD Operations, Customs Unit, Import Administration, International Trade Administration, U.S. Department of Commerce, 14th Street and Constitution Avenue, NW., Washington, DC 20230, telephone: (202) 482–4697. SUPPLEMENTARY INFORMATION: AGENCY: Background The Department has received timely requests, in accordance with 19 CFR 351.213(b)(2004), for administrative reviews of various antidumping and countervailing duty orders and findings with January anniversary dates. With respect to the antidumping duty order on Wooden Bedroom Furniture from the People’s Republic of China, the initiation of the antidumping duty administrative review for that case is being published in a separate initiation notice. Initiation of Reviews: In accordance with section 19 CFR 351.221(c)(1)(i), we are initiating administrative reviews of the following antidumping and countervailing duty orders and findings. We intend to issue the final results of these reviews not later than January 31, 2009. E:\FR\FM\27FEN1.SGM 27FEN1

Agencies

[Federal Register Volume 73, Number 39 (Wednesday, February 27, 2008)]
[Notices]
[Pages 10421-10422]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-3709]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[Docket 8-2008]


Foreign-Trade Zone 230 Greensboro, North CarolinaApplication for 
Subzone; Banner Pharmacaps, Inc.; (Pharmaceutical and Soft Gelatin 
Capsule Manufacturing) High Point, North Carolina

    An application has been submitted to the Foreign-Trade Zones (FTZ) 
Board (the Board) by the Piedmont Triad Partnership, grantee of FTZ 
230, requesting special-purpose subzone status with manufacturing 
authority for certain prescription pharmaceutical products and soft 
gelatin capsules at the manufacturing facility of Banner Pharmacaps, 
Inc. (Banner), located in High Point, North Carolina. The application 
was submitted pursuant to the Foreign-Trade Zones Act, as amended (19 
U.S.C. 81a-81u), and the regulations of the Board (15 CFR part 400). It 
was formally filed on February 12, 2008.
    The proposed subzone facility (51.3 acres, 2 buildings totaling 
263,000 sq. ft. approx. 40% of which is devoted to manufacturing) is 
located at 4125 Premier Drive in High Point, North Carolina.
    Banner is a contract manufacturer of soft gelatin capsules for 
prescription and over-the-counter (OTC) pharmaceuticals, and 
nutritional products. The Banner facility (500 employees) has requested 
authority to manufacture under zone procedures a variety of 
prescription pharmaceutical products that fall within HTSUS categories 
3004.50 and 3004.90 (duty-free). The initial products within these 
categories to be manufactured under FTZ procedures are a treatment for 
obesity, using active ingredient MK-0364; and, a drug for the 
prevention of organ rejection, using ISA 247. These ingredients are 
classified under HTSUS 2933.39 6.5% duty rate. Other potential products 
include treatments for obesity, migraines, organ rejection prevention, 
seizures, Parkinson's disease, viral infections, cold and cough, and 
prescription vitamin D. Banner is requesting authority to make these 
products with active ingredients that fall within the following 
categories: HTSUS 2915.90, 2921.30, 2922.49, 2933.39, 2933.79, 2935.00, 
and 3503.00. Active ingredients from these categories specifically 
cited in the application include valproic acid, amantadine, 
benzonatate, ethosuximide, cyclosporine, nimodipine, and zonisamide. 
Foreign-origin active ingredient inputs to be used in the manufacturing 
process (up to 50 percent of finished product value) have duty rates 
ranging from 3.7 percent to 6.5 percent, ad valorem. For each of the 
finished prescription pharmaceutical products (HTSUS 3004.50 and 
3004.90), the active ingredients may be combined with edible gelatin 
(HTSUS 3503.00 - 2.8 cents/kg. + 3.8/) and a non-active filler 
ingredient (HTSUS 3906.10 - 6.3/).
    Banner is also applying to produce over-the-counter pharmaceutical 
and nutritional products (HTSUS 3004.90 and 3004.50 duty-free, HTSUS 
1517.90 - 8%, and HTSUS 2106.90 - 6.4/) under zone procedures with 
requested authority limited to a single foreign-sourced input: edible 
gelatin (HTSUS 3503.00 - 2.8 cents/kg. + 3.8/).
    FTZ procedures would exempt Banner from customs duty payments on 
foreign materials used in export production. Some 5 to 10 percent of 
the plant's shipments are exported. On its domestic shipments, Banner 
could defer duty until the products are entered for consumption, and 
choose the duty-free rate that applies to the finished product for the 
foreign components used in

[[Page 10422]]

production. The company may also realize certain logistical/procedural 
savings related to zone-to zone transfers and direct delivery 
procedures, as well as savings on materials that become scrap/waste 
during manufacturing. The application indicates that FTZ procedures 
would help improve the plant's international competitiveness.
    In accordance with the Board's regulations, a member of the FTZ 
staff has been designated examiner to investigate the application and 
report to the Board.
    Public comment is invited from interested parties. Submissions 
(original and 3 copies) shall be addressed to the Board's Executive 
Secretary at the address below. The closing period for their receipt is 
April 28, 2008. Rebuttal comments in response to material submitted 
during the foregoing period may be submitted during the subsequent 15-
day period (to May 12, 2008).
    A copy of the application will be available for public inspection 
at each of the following locations: U.S. Department of Commerce Export 
Assistance Center, 342 North Elm St., Greensboro, NC 27401; and, Office 
of the Executive Secretary, Foreign-Trade Zones Board, Room 2111, U.S. 
Department of Commerce, 1401 Constitution Avenue, NW, Washington, D.C. 
20230-0002.
    For further information, contact Diane Finver at Diane--
Finver@ita.doc.gov or (202) 482-1367.

    Dated:February 15, 2008.
Andrew McGilvray,
Executive Secretary.
[FR Doc. E8-3709 Filed 2-26-08; 8:45 am]
BILLING CODE 3510-DS-S

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.